Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) has provided an announcement.
EZZ Life Science Holdings Limited has announced the appointment of Gary Liu as a director, effective 22 January 2026, and lodged an Initial Director’s Interest Notice with the ASX. The filing confirms that Liu currently holds no relevant interests in the company’s securities, either directly or indirectly, and has no disclosed interests in contracts, indicating a starting position free of shareholdings or related-party financial arrangements as he joins the board.
The most recent analyst rating on (AU:EZZ) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is an Australia-based company focused on life sciences, operating within the health and wellness sector. The company is listed on the ASX and its activities typically centre on science-driven consumer health products, although this specific notice does not detail its product portfolio or market focus.
Average Trading Volume: 72,460
Technical Sentiment Signal: Sell
Current Market Cap: A$92.44M
For detailed information about EZZ stock, go to TipRanks’ Stock Analysis page.